Changes to the Medicare Post-Acute Care Value-Based Purchasing Act (H.R. 3298) do not go far enough to address the underlying problems with the legislation, AHA today told the bill’s sponsors, Ways and Means Committee Chairman Kevin Brady (R-TX) and Rep. Ron Kind (D-WI). “Without a more balanced, budget-neutral approach that includes a broader set of valid, reliable quality measures, the PAC VBP program appears to function as a mechanism to reduce overall provider payments in perpetuity, rather than as a way to promote value,” wrote AHA. The legislation would withhold 5% of PAC payments in fiscal year 2020 and beyond, retaining up to half of the reduction as Medicare savings, and use only the Medicare Spending per Beneficiary and functional status measures to evaluate performance, among other concerns. “Until we have access to reliable, well validated data from the IMPACT Act, moving forward with a PAC VBP program would be premature,” AHA said. Given the magnitude of other recent payment reductions and requirements for PAC providers, the association said “now is not the time for a flawed PAC VBP program.”

Related News Articles

Perspective
America’s hospitals and health systems are committed to improving post-acute care — and patient outcomes — while ensuring changes to the system have the…
Headline
The Centers for Medicare & Medicaid Services today released its home health prospective payment system proposed rule for calendar year 2020.
Headline
The AHA today on Capitol Hill convened a panel of post-acute care leaders to brief lawmakers and their staff about the value these facilities provide to…
Headline
The Centers for Medicare…
Headline
The Centers for Medicare…
Insights and Analysis
Also in this weekly roundup of health care news: how mandated access to at-home palliative care has made all the difference for some patients; and a town’s…